Understanding the global measurement of willingness to pay in health.

Journal of Market Access & Health Policy
Jean A McDougallJörg Mahlich

Abstract

Objective: To understand the different methodologies used to elicit willingness to pay for health and the value of a statistical life year through surveys. Methodology: A systematic review of the literature was undertaken to identify studies using surveys to estimate either willingness to pay for health or the value of a statistical life year. Each study was reviewed and the study setting, sample size, sample description, survey administration (online or face to face), survey methodology, and results were extracted. The results of the studies were then compared to any published national guidelines of cost-effectiveness thresholds to determine their accuracy. Results: Eighteen studies were included in the review with 15 classified as willingness to pay and 3 value of a statistical life. The included studies covered Asia (n = 6), Europe (n = 4), the Middle East (n = 1), and North America (n = 5), with one study taking a global perspective. There were substantial differences in both the methodologies and the estimates of both willingness to pay and value of a statistical life between the different studies. Conclusion: Different methods used to elicit willingness to pay and the value of a statistical life year resulted in a wide ra...Continue Reading

References

Aug 1, 1984·American Journal of Public Health·A Muller, T J Reutzel
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R A HirthW G Weissert
Dec 16, 2003·Health Economics·Dorte Gyrd-Hansen
Nov 12, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Margaret M ByrneMaria E Suarez-Almazor
Nov 12, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Joseph T KingMark S Roberts
Oct 28, 2006·PharmacoEconomics·Martin J Buxton
Jan 9, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Angela RocchiElizabeth Miller
Dec 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Michael Barry, Lesley Tilson
Apr 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Scott D Grosse
Sep 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ana BobinacWerner B F Brouwer
Jan 26, 2011·International Journal of Technology Assessment in Health Care·Irina CleemputMark Leys
Apr 15, 2011·Risk Analysis : an Official Publication of the Society for Risk Analysis·Kevin Haninger, James K Hammitt
Jan 1, 2010·Frontiers in Pharmacology·Steven Simoens
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·José Manuel RodriguezPaloma Gonzalez
Jan 25, 2013·ClinicoEconomics and Outcomes Research : CEOR·Montarat ThavorncharoensapPitsaphun Werayingyong
Jul 16, 2013·Social Science & Medicine·Angela RobinsonUNKNOWN EuroVaQ Team
Oct 17, 2013·Cost Effectiveness and Resource Allocation : C/E·Takeru ShiroiwaShunya Ikeda
Nov 19, 2013·Targeted Oncology·Kim PauwelsSteven Simoens
Jul 6, 2014·BMC Health Services Research·Jesus Martín-FernándezSonia García-Pérez
Aug 28, 2014·The New England Journal of Medicine·Peter J NeumannMilton C Weinstein
Nov 5, 2014·ClinicoEconomics and Outcomes Research : CEOR·Asrul Akmal ShafieMohammed Azmi Ahmad Hassali
Dec 3, 2014·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Margreet FrankenAdri Steenhoek
Apr 18, 2015·Bulletin of the World Health Organization·Elliot MarseilleSydney Rosen
Oct 7, 2015·BMJ Open·Khachapon Nimdet, Surachat Ngorsuraches
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·N Moradi, A Rashidian
Jan 6, 2016·Social Science & Medicine·Marlies AhlertLars Schwettmann
May 15, 2016·Accident; Analysis and Prevention·Zhao YangXin Xu
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura Vallejo-TorresPedro Serrano-Aguilar
Dec 19, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Beth WoodsKarl Claxton
Dec 21, 2016·Bulletin of the World Health Organization·Melanie Y BertramSuzanne R Hill

❮ Previous
Next ❯

Citations

Jun 12, 2021·Cost Effectiveness and Resource Allocation : C/E·César Augusto Guevara-CuellarElizabeth Parody-Rúa
Oct 2, 2021·Clinical Orthopaedics and Related Research·R Andrew GlennieChristopher S Bailey
Oct 13, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Matthew GreenhawtChristopher D Codispoti

❮ Previous
Next ❯

Software Mentioned

Google Finance

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.